Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hm781-36
2. Hm781-36b
1. 1092364-38-9
2. Hm781-36b
3. Nov120101
4. Unii-oei6oou6ik
5. Poziotinib [inn]
6. Nov-120101
7. Hm-781-36b
8. Poziotinib [usan]
9. 1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one
10. 1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one
11. Oei6oou6ik
12. Hm-781-36
13. Nov-1201
14. Mfcd28044290
15. Hm 781-36b
16. 1-[4-[[4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one
17. 2-propen-1-one, 1-[4-[[4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-
18. 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one
19. 1-[4-({4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)piperidin-1-yl]prop-2-en-1-one
20. 2-propen-1-one, 1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)oxy)-1-piperidinyl)-
21. Hm-78136b
22. Poziotinib [who-dd]
23. C23h21cl2fn4o3
24. Poziotinib (hm781-36b)
25. Gtpl7903
26. Schembl3391764
27. Chembl3545154
28. Dtxsid80148853
29. Ex-a528
30. Hms3673k03
31. Amy24248
32. Bcp08270
33. Who 9736
34. Bdbm50468247
35. Nsc783296
36. Nsc800856
37. S7358
38. Zinc95930125
39. Akos026674078
40. Ccg-264748
41. Cs-3942
42. Db12114
43. Nov 120101
44. Nsc-783296
45. Nsc-800856
46. Sb16882
47. Ncgc00386427-01
48. Ncgc00386427-02
49. Ac-29021
50. As-74851
51. Bp161454
52. Da-47945
53. Hy-15730
54. Sy235762
55. Hm 781-36
56. Ft-0752903
57. A13044
58. J-690026
59. Q27088426
60. 1-(4-((4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl)oxy(piperidin-1-yl)prop-2-en-1-one
61. 1-[4-[4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazoline-6-yloxy]-1-piperidinyl]-2-propene-1-one
Molecular Weight | 491.3 g/mol |
---|---|
Molecular Formula | C23H21Cl2FN4O3 |
XLogP3 | 5.4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 6 |
Exact Mass | 490.0974741 g/mol |
Monoisotopic Mass | 490.0974741 g/mol |
Topological Polar Surface Area | 76.6 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 684 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?